Document is current
Any future updates will be listed below
-
Authors
Ansari, Mohammad Sufyan
Chauhan, Varnit
Singh, Aashi
Akhtar, Areej
Chaudhary, Nisha
Tyagi, Reegina
Divya,
Husain, Kashif https://orcid.org/0009-0006-9624-027X
Sharma, Sheetal
Alam, Ruquaiya
Shakir, Md
Pracha, Mehak
Anjum, Samreen https://orcid.org/0009-0007-8473-0631
Nadeem, Mohd
Taneja, Prial
Faizan, Md Imam
Azmi, Iqbal
Iyer, Aditya Ramdas
Gupta, Pragya
Nafiz, Mehwish
Ali, Shayan
Uddin, Insha Mohi
Javid, Momina
Bhat, Zahoor Ahmad
Palani, Hamenth Kumar
Srivastava, Amit Kumar
Mabalirajan, Ulaganathan
Mathews, Vikram https://orcid.org/0000-0001-9417-2353
Husain, Mohammad
Ramalingam, Sivaprakash
Kharya, Gaurav https://orcid.org/0000-0003-2181-1825
Ahmad, Tanveer https://orcid.org/0009-0000-4562-566X
-
Funding
Funding for this research was provided by:
Indian Council of Medical Research (ICMR-JRF-2020-HRD (31) (135027))
- License Information
-
More Information
Article History
Received: 20 July 2025
Accepted: 29 December 2025
First Online: 17 January 2026
Competing interests
: T.A. and Cellogen Therapeutics have filed a patent application related to the CAR T cell engineering strategies described in this study. All other authors declare no competing financial or non-financial interests.
